JNJ-46778212

产品说明书

Print
Chemical Structure| 1363281-27-9 同义名 : VU 0409551
CAS号 : 1363281-27-9
货号 : A693152
分子式 : C20H17FN2O3
纯度 : 99%
分子量 : 352.359
MDL号 : MFCD29047143
存储条件:

Pure form Sealed in dry, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(297.99 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 The metabotropic glutamate receptor subtype 5 (mGlu5) is a G protein-coupled receptor implicated in schizophrenia. JNJ-46778212 is a mGlu5 positive allosteric modulator with an EC50 value of 260nM and with 84% Glu Max. It is highly selective for mGlu5 relative to mGlu1–4,6–8 at 10μM. JNJ-46778212 showed excelled central nervous system penetration with Kps of 1.0 and 2.3 for mouse and rat, respectively. It was inactive in the hERG patch clamp (22% inhibition at 3μM) and was clean in a CV-relevant ion channel panel (hERG, Ca, Na channels, IC50s >10μM). JNJ-46778212 exhibited robust dose-responsive efficacy with a maximum reversal of ∼78% at 100mg/kg (p.o.) and a minimum effective dose of 10mg/kg (p.o.) with an ED50 value of 23mg/kg in a preclinical assay. In an investigational new drug-enabling study, chronic administration of JNJ-46778212 at a dose of 360mg/kg (p.o.) for 30 days induced neuronal death (indicated by Fluoro-Jade C staining) in rats.[1]
作用机制 JNJ-46778212 is a potent, selective, and orally bioavailable positive allosteric modulator of mGlu5.[1]
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.84mL

0.57mL

0.28mL

14.19mL

2.84mL

1.42mL

28.38mL

5.68mL

2.84mL

参考文献

[1]Conde-Ceide S, Martínez-Viturro CM, Alcázar J, Garcia-Barrantes PM, Lavreysen H, Mackie C, Vinson PN, Rook JM, Bridges TM, Daniels JS, Megens A, Langlois X, Drinkenburg WH, Ahnaou A, Niswender CM, Jones CK, Macdonald GJ, Steckler T, Conn PJ, Stauffer SR, Bartolomé-Nebreda JM, Lindsley CW. Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia. ACS Med Chem Lett. 2015 May 20;6(6):716-20. doi: 10.1021/acsmedchemlett.5b00181